Recruitment status changed
Before: Active not recruiting. After: Completed.
Study sponsor: Cumberland Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: Active not recruiting. After: Completed.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Incidence of Treatment-Emergent Adverse Events (Safety & Tolerability). After: Measure: Incidence of Treatment-Emergent Adverse Events.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Incidence of Treatment-Emergent Adverse Events (safety & tolerability). After: Measure: Incidence of Treatment-Emergent Adverse Events (Safety & Tolerability).
Before: Estimated. After: Actual.
Before: 48 participants (planned). After: 46 participants (actual).
Before: Estimated. After: Actual.
Before: Sep 2025. After: 6 Mar 2024.